---
aliases:
- (Edinger et al., 2021)
author: Edinger, Jack D. and Arnedt, J. Todd and Bertisch, Suzanne M. and Carney,
  Colleen E. and Harrington, John J. and Lichstein, Kenneth L. and Sateia, Michael
  J. and Troxel, Wendy M. and Zhou, Eric S. and Kazmi, Uzma and Heald, Jonathan L.
  and Martin, Jennifer L.
citekey: edinger2021BehavioralPsychologicalTreatments
date_added: '2025-03-23'
doi: 10.5664/jcsm.8986
journal: 'Journal of clinical sleep medicine: JCSM: official publication of the American
  Academy of Sleep Medicine'
title: 'Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults:
  An American Academy of Sleep Medicine Clinical Practice Guideline'
year: '2021'

---
# Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
- [PDF Link](zotero://open-pdf/library/items/Z2H5T6KH)

Citation: [@edinger2021BehavioralPsychologicalTreatments]

***
# TL;DR (Summary)
- CBT-I showed clinically significant improvements in remission and responder rates compared to control conditions across 49 studies.
- BTIs demonstrated clinically significant improvements in remission rate, responder rate, and sleep quality in 7 studies.
- Stimulus control, sleep restriction therapy, and relaxation therapy showed clinically significant improvements in at least one critical outcome in their respective studies.
- The guideline provides updated recommendations based on a comprehensive systematic review and meta-analysis using the GRADE methodology.
- It offers a structured approach to assessing the quality of evidence and the strength of recommendations for behavioral and psychological treatments for chronic insomnia.
- Authors strongly recommend CBT-I as the treatment of choice due to its superior long-term effectiveness and minimal side effects.
- They suggest that clinicians should discuss different CBT-I delivery modalities with patients to align treatment with availability, affordability, and patient preferences.
- Authors emphasize the need for education of front-line providers on effective alternatives to sleep hygiene.
- The guideline highlights the variability in CBT-I components across studies, yet notes that this did not systematically impact treatment effectiveness.
- It addresses the challenges patients face in accessing CBT-I, including cost and geographic availability of trained providers.
- The guideline notes the lack of sufficient evidence to recommend certain single-component therapies like paradoxical intention and intensive sleep retraining.

# 中文摘要 (TL;DR)
- CBT-I在49項研究中顯示出與對照條件相比，緩解率和反應率有臨床上顯著的改善。
- BTIs在7項研究中顯示出緩解率、反應率和睡眠質量有臨床上顯著的改善。
- 刺激控制、睡眠限制療法和放鬆療法在各自的研究中至少在一個關鍵結果上顯示出臨床上顯著的改善。
- 該指南基於使用GRADE方法的全面系統性評價和-meta分析，提供了更新的建議。
- 它為評估慢性失眠的行為和心理治療的證據質量和建議強度提供了一個結構化的方法。
- 作者強烈推薦CBT-I作為首選治療，因其長期效果優越且副作用最小。
- 他們建議臨床醫生應與患者討論不同的CBT-I傳遞方式，以根據可用性、可負擔性和患者偏好調整治療。
- 作者強調需要對前線提供者進行關於睡眠衛生有效替代方案的教育。
- 該指南強調了不同研究中CBT-I組成的變化性，但指出這並未系統性地影響治療效果。
- 它提到了患者在獲取CBT-I時面臨的挑戰，包括成本和訓練有素的提供者在地理上的可用性。
- 指南指出，缺乏足夠的證據來推薦某些單一組成療法，如矛盾意圖和密集睡眠再訓練。
